Sun Yat-sen University Cancer Center

News

High quality clinical trials at Sun Yat-sen University Cance...

November 02, 2023

On October 27, 2023, the Food and Drug Administration approved toripalimab-tpzi (LOQTORZ) with cisplatin and gemcitabine...
Prof. Xu Ruihua from Sun Yat-sen University Cancer Center ga...

October 24, 2023

In the afternoon of October 21, 2023, Prof. Xu Ruihua from Sun Yat-sen University Cancer Center gave an oral presentatio...
Prof. Gao Song and Prof. Han Hui’s research group achieved n...

October 19, 2023

The loss of T cell effector function in the tumor microenvironment is one of the main reasons for immunotherapy failure....
Research conducted by Sun Yat-sen University Cancer Center r...

September 21, 2022

Epigenetic modifications, such as DNA methylation and histone modification, are one of the most important factors in th...

< 7 8 9 10 11 >